IFNA1 and colorectal cancer: Second, developing efficient and accessible detection methods for measuring RIG‐I expression in colorectal cancer patients would support clinical studies evaluating the effectiveness of IFN‐α and anti‐PD‐1 combination therapy in patients with high RIG‐I expression.